Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Fish and Richardson
Medtronic
Julphar
Johnson and Johnson
Farmers Insurance
Argus Health
Queensland Health

Generated: May 26, 2018

DrugPatentWatch Database Preview

RESERPINE AND HYDROCHLOROTHIAZIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Reserpine And Hydrochlorothiazide patents expire, and when can generic versions of Reserpine And Hydrochlorothiazide launch?

Reserpine And Hydrochlorothiazide is a drug marketed by Barr, Sandoz, and West Ward. and is included in four NDAs.

The generic ingredient in RESERPINE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; reserpine. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.
Summary for RESERPINE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for RESERPINE AND HYDROCHLOROTHIAZIDE
Synonyms for RESERPINE AND HYDROCHLOROTHIAZIDE
C33H40N2O9.C7H8ClN3O4S2
H.R.-50
HYDRO-SERP "25"
HYDRO-SERP "50"
HYDROCHLOROTHIAZIDE W/ RESERPINE
HYDROCHLOROTHIAZIDE; RESERPINE
LS-178646
RESERPINE AND HYDROCHLOROTHIAZIDE-50
SCHEMBL4265419

US Patents and Regulatory Information for RESERPINE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr RESERPINE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; reserpine TABLET;ORAL 084580-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West Ward RESERPINE AND HYDROCHLOROTHIAZIDE-50 hydrochlorothiazide; reserpine TABLET;ORAL 088189-001 May 10, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr RESERPINE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; reserpine TABLET;ORAL 084579-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz RESERPINE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; reserpine TABLET;ORAL 088200-001 Jan 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
McKesson
Fuji
UBS
Baxter
Queensland Health
Harvard Business School
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.